M.B.A., Yale School of Management; B.A., international affairs, George Washington University
Summary of Experience
Mr. Ellman specializes in the application of microeconomics, statistics, and finance to complex commercial litigations and government investigations involving antitrust and competition, drug safety and product liability, intellectual property, and general damages issues. His case work has included market analyses and the assessment of competitive effects in major antitrust matters and actual and proposed mergers. He has supported statistical analysis of market surveillance, clinical trial, and observational study data to assess liability in product liability suits pertaining to the pharmaceutical, medical device, and automotive industries. Mr. Ellman has also conducted statistical analysis, market research, and other economic analysis to evaluate the appropriateness of class certification in antitrust and commercial disputes, as well as to assess liability and damages. He has worked across a wide range of industries, including pharmaceuticals and managed health care, consumer packaged goods, information technology, and financial services.
Mr. Ellman has provided litigation support to leading academics from top universities. Prior to joining Analysis Group, Mr. Ellman worked at the U.S. Department of Commerce International Trade Administration, where he performed complex price and cost analyses, and conducted on-site forensic audits of foreign corporations to calculate and ensure the implementation of protective tariffs to secure the sustainable competitiveness of U.S. industries. He has authored articles on assessing the effects of most-favored-nation clauses, the evolving standards of class certification in antitrust cases, the appropriate analysis and interpretation of post-marketing surveillance data in product liability cases, and the use of average wholesale price in antitrust matters.